详情页 - 四川省肿瘤医院知识库

当前位置：首页 > 详情页

Unlocking the future: mitochondrial genes and neural networks in predicting ovarian cancer prognosis and immunotherapy response

文献详情

资源类型：

Pubmed体系：

作者：

机构： [1]Department of Obstetrics and Gynecology, Peking University People's Hospital, Beijing, China. [2]Cancer Research Center, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing, China. [3]Department of Thoracic Surgery, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China.

出处：

DOI：

ISSN：

关键词： Ovarian cancer (OC) mitochondria prognosis immunotherapy neural network

摘要：

Mitochondrial genes are involved in the tumor metabolism of ovarian cancer (OC), affecting immune cell infiltration and treatment response. We aimed to utilize mitochondrial genes to predict OC prognosis and immunotherapy response.The prognosis data, immunotherapy efficacy and next generation sequencing data of OC patients were downloaded from The Cancer Genome Atlas Program (TCGA) and Gene Expression Omnibus (GEO). Mitochondrial genes were sourced from the MitoCarta3.0 database. Seventy percent of the patients were randomly selected as the discovery cohort for model construction, while the remaining 30% constituted the validation cohort for model assessment. Using the expression of mitochondrial genes as the predictor variable and based on the neural network algorithm, the overall survival (OS) time and immunotherapy efficacy (complete or partial response) of the included patients were predicted.There were 375 OC patients included to construct the prognostic model, and 26 patients were included to construct the immune efficacy model. The average area under the receiver operating characteristic curve (AUC) of the prognostic model was: 0.7268 [95% confidence interval (CI), 0.7258-0.7278] in the discovery cohort and 0.6475 (95% CI: 0.6466-0.6484) in the validation cohort. The average AUC of the immunotherapy efficacy model was: 0.9444 (95% CI: 0.8333-1.0000) in the discovery cohort and 0.9167 (95% CI: 0.6667-1.0000) in the validation cohort.The application of mitochondrial genes and neural networks shows potential in predicting the prognosis and immunotherapy response in OC patients. And this approach could provide valuable insights for personalized treatment strategies.Copyright © 2025 AME Publishing Company. All rights reserved.

基金：

语种：

PubmedID：

中科院(CAS)分区：

出版当年[2025]版：

无

最新[2023]版：

大类 | 4 区医学

小类 | 4 区肿瘤学

第一作者：

第一作者机构： [1]Department of Obstetrics and Gynecology, Peking University People's Hospital, Beijing, China.

通讯作者：

推荐引用方式(GB/T 7714)：

APA：

MLA：

相关文献

[1]Develop prediction model to help forecast advanced prostate cancer patients' prognosis after surgery using neural network [2]A Neural Network for Segmenting Tumours in Ultrasound Rectal Images [3]Improvement of Neoantigen Identification Through Convolution Neural Network. [4]Investigation on aortic hemodynamics based on physics-informed neural network [5]神经网络模型应用于数据缺失机制识别的可行性分析 [6]Transformer-Integrated Hybrid Convolutional Neural Network for Dose Prediction in Nasopharyngeal Carcinoma Radiotherapy [7]AirNet: Fused analytical and iterative reconstruction with deep neural network regularization for sparse-data CT. [8]Neural network-based prognostic predictive tool for gastric cardiac cancer: the worldwide retrospective study [9]Dosimetric evaluation of synthetic CT image generated using a neural network for MR-only brain radiotherapy. [10]An Ultrasonic Image Recognition Method for Papillary Thyroid Carcinoma Based on Depth Convolution Neural Network